Evogene Ltd (EVGN) stock has fallen -74.89% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives EVGN stock a score of 33 out of a possible 100.
That rank is influenced by a short-term technical score of 6. EVGN's rank also includes a long-term technical score of 24. The fundamental score for EVGN is 70. In addition to the average rating from Wall Street analysts, EVGN stock has a mean target price of $10.33. This means analysts expect the stock to climb 814.42% over the next 12 months. EVGN has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on EVGN!